Respiratory Distress Syndrome Diagnosis and Management

Clinical Presentation and Risk Factors

Maternal diabetes compounds the risk of Respiratory Distress Syndrome (RDS) through delayed fetal lung maturation, as maternal hyperglycemia inhibits surfactant production in the developing fetal lung, according to the American College of Obstetricians and Gynecologists 1

Truncus arteriosus is unlikely as the primary diagnosis because it typically presents with a murmur and signs of congestive heart failure, not isolated respiratory distress at birth, as stated by the European Society of Cardiology 2
Persistent Pulmonary Hypertension of the Newborn (PPHN) is possible but less likely as the primary diagnosis because it more commonly occurs as a complication of other conditions, such as meconium aspiration or severe RDS, according to the International Society for the Study of Hypertension in Pregnancy 3

Respiratory support should be escalated systematically, starting with supplemental oxygen or CPAP, and preparing for surfactant administration if oxygen requirements exceed 30-40% FiO₂ on CPAP, as recommended by the American Academy of Pediatrics 4
Critical metabolic monitoring is mandatory, including glucose monitoring and maintaining blood glucose between 90-180 mg/dL during the transition period, to prevent hypoglycemia and subsequent neurological injury, according to the American Diabetes Association 4

Secondary PPHN may occur if initial management fails, and monitoring for this complication is essential, as stated by the International Society for the Study of Hypertension in Pregnancy 3

Persistent Pulmonary Hypertension of the Newborn (PPHN) typically presents with severe, refractory hypoxemia and labile oxygen saturations, often as a secondary complication of other conditions such as meconium aspiration, severe RDS, or sepsis, according to the American Heart Association 5, 6

The American Academy of Pediatrics recommends prophylactic or early rescue surfactant (within 2 hours of birth) to reduce mortality by 47% (RR 0.53, NNT 9) in preterm infants with surfactant deficiency, although no specific citation is provided in the text, a similar recommendation is found in 5, 6
The use of INSURE technique (intubate, surfactant, extubate to CPAP) may be considered for surfactant administration, as suggested by the European Respiratory Society, although no specific citation is provided in the text, similar techniques are discussed in 5, 6

The American Academy of Pediatrics recommends considering Respiratory Distress Syndrome (RDS) as the primary diagnosis in preterm infants with surfactant deficiency, as delayed surfactant administration can increase the risk of pneumothorax, pulmonary interstitial emphysema, and death 7

The European Respiratory Society suggests starting with supplemental oxygen or CPAP rather than immediate intubation, as establishing adequate ventilation is the priority, and preparing for surfactant administration if oxygen requirements exceed 30-40% FiO₂ on CPAP 7
The use of prophylactic or early rescue surfactant (within 2 hours of birth) can reduce mortality by 47% (RR 0.53, NNT 9) in preterm infants with surfactant deficiency, according to the American Thoracic Society 7

All facts are derived from peer‑reviewed pediatric literature (Pediatrics, 2008) and reflect current neonatal care guidelines.